My Companies
Notification
Account
Log Out
Login
RPG Life Sciences to transfer API business to subsidiary RPG Active Pharma; InvAscent to invest up to INR 243 cr, and RPG Active Pharma to acquire Actis Generics, marking its first acquisition.
RPG Life Sciences Partners With InvAscent In ₹243.33 Crore API Investment
RPG Life Sciences Agrees To Acquire Raghava API Business For ₹135 Crore
RPG Life Sciences Approves Up To ₹135 Crore Raghava API Acquisition
RPG Life Sciences Approves ₹135 Crore API Business Acquisition
RPG Life Sciences Approves ₹243 Crore API Subsidiary Investment And Acquisition